1-[(2,5-difluorophenyl)methyl]-1,4-diazepane, 95.0%, 1g

Fmoc-R-3-amino-4-(3,4-difluorophenyl)-butyric acid, 97%, 250mg

Cholesteryl palmitate, min. 95%, pure, 5 g, plastic packaging.

2-(3-FLUOROBENZYL)SUCCINIC ACID, 95.0%, 100mg

5-((tert-Butoxycarbonyl)amino)nicotinic acid, 95.0%, 1g

2-(4-(Benzyloxy)-2-ethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

(S)-1,4-Di-tert-butyl 2-methyl piperazine-1,2,4-tricarboxylate, 95.0%, 250mg

tert-butyl 2-{[3-(4-chlorophenyl)-2-hydroxypropanoyl]amino}ethylcarbamate, 1g

2-(4-Methyl-2-oxo-1,2-dihydropyridin-1-yl)acetic acid, 98+%, 10g

rac-(1R,5S,6R)-3-azabicyclo[3.2.0]heptan-6-ol hydrochloride, 95.0%, 250mg

Cryo labels On the sheet white, 33 x 13 mm, Gesch. for, 1.5/2 ml vials, 20 pieces

2-Amino-3-methoxybenzoic acid, 97.0%, 1g

Biadamantylidene, 95.0%, 1g